Clinical trial
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and…
NCT00004800 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00004800 |
|---|---|
| Title | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Istituto Superiore di Sanità |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pertussis |
| Intervention type | Biological |
| Interventions | diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis, diphtheria-tetanus vaccine |
| Enrollment | 13,250 |
| Start date | Sep 1, 1992 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: